Atlas Trials

A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy

Clinical trial NCT07475754 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07475754
Sponsor
Peking Union Medical College Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy (DMD)
Start date
2026-03-23
Primary completion
2026-05-30
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.